Radiopharm Theranostics Ltd (RADX) stock
RADXNasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as RDPTF
$0.76−0.03 (-3.80%)
Close on Nov 13, 2026Market cap $8.98MP/E –Yield –
Radiopharm Theranostics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Radiopharm Theranostics's enterprise value was $1.90M on Nov 11, 2026, against $595.15K a year earlier. Over the last 2 years it ranged from -$23.96M to $10.09M, with a median of -$1.97M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.90M | -63.3% |
| 2025 | Dec 31, 2025 | $5.17M | – |
| 2024 | Dec 31, 2024 | -$13.56M | – |
See a number that looks wrong?